Publication
Number of items: 5.
April 2024
  • Impact of Very Low Dose Rivaroxaban in Addition to Dual Antiplatelet Therapy on Endogenous Fibrinolysis in Acute Coronary Syndrome: The VaLiDate-R study. (2024) Ying X. Gue, Vassilios Memtsas, Rahim Kanji, David Wellsted, Amanda Busby, Megan Smith, Enric Vilar, Alisdair Ryding, Deepa J. Arachchillage and Diana Gorog
    • 10 September 2020
  • Aspirin related platelet reactivity as a determinant of ten year survival in high risk non-ST segment elevation myocardial infarction (NSTEMI) patients. (2020) Nazish Khan, Mamas A. Mamas, Alexandra Moss, Diana A. Gorog, Peter Nightingale, Angel Armesilla, Andrew Smallwood, Shahzad Munir, Saib Khogali, Ben Wrigley and James M. Cotton
    • May 2014
  • Global Thrombosis Test (GTT) can detect major determinants of haemostasis including platelet reactivity, endogenous fibrinolytic and thrombin generating potential. (2014) Diana Gorog, J. Yamamoto, N. Inoue, K. Otsui and H. Ishii
    • 2009
  • Shear-induced global thrombosis test of native blood: Pivotal role of ADP allows monitoring of P2Y12 antagonist therapy. (2009) S. Saraf, D. Wellsted, S. Sharma and D.A. Gorog
    • 1995
  • Flurbinitroxybutylester : a novel anti-inflammatory drug has enhanced antithrombotic activity. (1995) G. Cirino, C. Cicala, F. Mancuso, A. R. Baydoun and J. L. Wallace